Pfizer sales miss as breast cancer drug disappoints
(Reuters) – Leading U.S. drugmaker Pfizer Inc racked up its biggest miss on sales in a year in the first quarter, hurt by lower-than-expected sales of blockbuster breast cancer drug Ibrance and arthritis drug Xeljanz.
Exclusive: Hasbro to acquire Power Rangers, other franchises from Saban: sources
(Reuters) – Toy maker Hasbro Inc has agreed to acquire children’s entertainment and merchandising franchises, including the characters of the superhero TV show Power Rangers, from Saban Entertainment for around $520 million in cash and stock, people f…
Futures little changed as trade, inflation worries persist
(Reuters) – U.S. stock index futures treaded water on Tuesday, as strong earnings failed to excite investors who instead fretted about inflation, rising costs and protectionist policies.
Keytruda sales power Merck to quarterly beat
(Reuters) – Drugmaker Merck & Co reported a better-than-expected first-quarter profit on Tuesday, helped by a more than 150 percent rise in sales of cancer drug Keytruda.
Swiss trader Trafigura bulks up management committee
LONDON (Reuters) – Trafigura has tripled the size of its management committee, bolstering the position of CEO Jeremy Weir while also giving more responsibility to the next generation of potential leaders, the Swiss commodities trader said on Tuesday.
Pfizer tops profit estimates, driven by Prevnar sales
(Reuters) – Pfizer Inc’s quarterly profit topped Wall Street forecasts, driven by stronger-than-expected sales of pneumonia vaccine Prevnar.
Swiss trader Trafigura sets up new 9-person management committee
LONDON (Reuters) – Trafigura has set up a new management committee comprised of nine executives including chief executive Jeremy Weir, the Swiss commodities trader said on Tuesday.
UK competition regulator sends Fox-Sky verdict to government
LONDON (Reuters) – Britain’s competition regulator submitted its view on Rupert Murdoch’s attempt to buy all of Sky to the government on Tuesday, giving minister Matt Hancock 30 working days to deliver his final ruling on the deal.
Dollar goes positive for year before Fed meeting
LONDON (Reuters) – The dollar broke into positive territory for the year on Tuesday and bond yields were creeping higher again, as rising oil prices fueled bets that the Federal Reserve will flag more U.S. rate hikes this week.
China’s HNA drops bid to buy Scaramucci’s SkyBridge due to regulatory hold-up
(Reuters) – Chinese conglomerate HNA Group has dropped its bid for most of SkyBridge Capital, a hedge fund investment firm founded by U.S. President Donald Trump’s former aide Anthony Scaramucci, as the deal was still stuck with U.S. regulators after m…
